Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Human TIGIT His-Tag Protein, CF

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Manufacturer:  R&D Systems™ 9525TG050

Catalog No. 95-25T-G050

Due to product restrictions, please to purchase or view availability for this product.

This item is not returnable. View return policy



Measured by its binding ability in a functional ELISA. When Recombinant Human CD155/PVR Fc Chimera (Catalog # 9174-CD ) is immobilized at 2.5 μg/mL (100 μL/well), Recombinant Human TIGIT binds with an ED50 of 0.3-1.5 μg/mL.


>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
Chinese Hamster Ovary cell line, CHO-derived human TIGIT protein Met22-Ala136, with a C-terminal 6-His tag
<0.10 EU / 1 µg of the protein by the LAL method.
Lyophilized from a 0.2 µm filtered solution in PBS, EDTA and Trehalose
Lyophilized from a 0.2 µm filtered solution in PBS, EDTA and Trehalose.
M.W. (Observed): 10-24 kDa, reducing conditions; M.W. (theoretical): 13 kDa
50 µg
12 months from date of receipt, <= -20 °C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.
Reconstitute at 200 µg/mL in PBS.
Product Certifications


Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit